EP Biocomposites Complete Financial Statements
EPBIO • Review detailed financials to uncover trends, confirm thesis & journal trades
6 Years of Data
2025 - 2020
Complete Financial Data Export
Export complete financial statements for EP Biocomposites (EPBIO).
Downloads include all available records across all periods.
For market performance, see the
EPBIO stock price today
.
Profitability Ratios
Net Profit Margin
8.33%
2025 data
EBITDA Margin
16.67%
2025 data
Operating Margin
15.00%
2025 data
Return on Assets
5.88%
2025 data
Return on Equity
9.09%
2025 data
Balance Sheet Ratios
Current Ratio
4.67
2025 data
Debt to Equity
1.55
2025 data
Equity Ratio
64.71%
2025 data
Asset Turnover
0.71
2025 data
Year-over-Year Growth Analysis
Comparing March 2025 vs Period
Revenue Growth
-100.0%
Year-over-Year
Net Profit Growth
-100.0%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-100.0%
Year-over-Year
Assets Growth
+13.3%
Year-over-Year
Equity Growth
+10.0%
Year-over-Year
Liabilities Growth
+13.3%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 12 | 12 | 7 | 8 | 3 | 1 |
| Expenses | 0 | 10 | 10 | 6 | 7 | 3 | 1 |
| EBITDA | 0 | 2 | 2 | 1 | 1 | 1 | 0 |
| Operating Profit Margin % | 0.00% | 15.00% | 12.00% | 13.00% | 17.00% | 16.00% | 8.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 2 | 1 | 1 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Earnings Per Share (₹) | 0.00 | 6.13 | 6.84 | 3.94 | 9.48 | 6.97 | 0.61 |
Related Pages for EP Biocomposites
Additional stock information and data for EPBIO
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 17 | 15 | 12 | 9 | 1 | 1 |
| Current Assets | 14 | 13 | 9 | 9 | 1 | 1 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 16 | 15 | 11 | 9 | 1 | 1 |
| LIABILITIES | ||||||
| Total Liabilities | 17 | 15 | 12 | 9 | 1 | 1 |
| Current Liabilities | 3 | 1 | 1 | 2 | 0 | 0 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 11 | 10 | 8 | 2 | 0 | 0 |
| Share Capital | 2 | 2 | 2 | 1 | 0 | 0 |
| Reserves & Surplus | 9 | 8 | 7 | 1 | 0 | 0 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 |
|---|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | -1 | -4 | 0 | 0 |
| Investing Activities | 0 | 0 | 0 | -1 | 0 | 0 |
| Financing Activities | 1 | 1 | 3 | 5 | 0 | 0 |
| Net Cash Flow | 0 | -1 | 2 | 0 | 0 | 0 |